Skip to main content
. 2002 Aug 5;3:14. doi: 10.1186/1471-2296-3-14

Figure 1.

Figure 1

Mean change in AM instantaneous symptom scores for desloratadine 2.5-, 5-, 7.5-, 10-, and 20-mg tablets compared with placebo for days 2–15. Mean changes from baseline are least-square means based on ANOVA model with treatment and center effects. TSS = total symptom score is nasal + nonnasal scores. (*P < .01 versus placebo.)